Frey N - Search Results

1

Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation.

Luedde M, Ehlermann P, Weichenhan D, Will R, Zeller R, Rupp S, Müller A, Steen H, Ivandic BT, Ulmer HE, Kern M, Katus HA, Frey N. Luedde M, et al. Among authors: frey n. Cardiovasc Res. 2010 Jun 1;86(3):452-60. doi: 10.1093/cvr/cvq009. Epub 2010 Jan 18. Cardiovasc Res. 2010. PMID: 20083571

2

[A transgenic animal model: new possibilities for cardiovascular research].

Franz WM, Frey N, Müller O, Kübler W, Katus HA. Franz WM, et al. Among authors: frey n. Z Kardiol. 1995;84 Suppl 4:17-32. Z Kardiol. 1995. PMID: 8585270 Review. German.

3

[Clinical aspects and follow-up in dilated cardiomyopathy].

Grünig E, Brown B, Franz W, Zehelein J, Rottbauer W, Frey N, Scheffold T, Katus HA. Grünig E, et al. Among authors: frey n. Z Kardiol. 1995;84 Suppl 4:39-40. Z Kardiol. 1995. PMID: 8585272 Review. German.

4

Transgenic animal models: new avenues in cardiovascular physiology.

Franz WM, Mueller OJ, Hartong R, Frey N, Katus HA. Franz WM, et al. Among authors: frey n. J Mol Med (Berl). 1997 Feb;75(2):115-29. doi: 10.1007/s001090050096. J Mol Med (Berl). 1997. PMID: 9083929

5

Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters.

Franz WM, Rothmann T, Frey N, Katus HA. Franz WM, et al. Among authors: frey n. Cardiovasc Res. 1997 Sep;35(3):560-6. doi: 10.1016/s0008-6363(97)00154-5. Cardiovasc Res. 1997. PMID: 9415302

6

Cardiac troponins in patients with chest pain.

Katus HA, Frey N, Müller-Bardorff M. Katus HA, et al. Among authors: frey n. N Engl J Med. 1998 Apr 30;338(18):1314-5. N Engl J Med. 1998. PMID: 9565496 No abstract available.

7

[Value of laboratory parameters in risk assessment of patients with coronary heart disease and chronic myocardial ischemia].

Frey N, Müller-Bardorff M, Katus HA. Frey N, et al. Z Kardiol. 1998;87 Suppl 2:100-5. doi: 10.1007/s003920050548. Z Kardiol. 1998. PMID: 9827468 Review. German.

8

Biochemical markers in the diagnosis of coronary artery disease.

Hartmann F, Kampmann M, Frey N, Müller-Bardorff M, Katus HA. Hartmann F, et al. Among authors: frey n. Eur Heart J. 1998 Nov;19 Suppl N:N2-7. Eur Heart J. 1998. PMID: 9857931 Review.

9

The 2.3 kb smooth muscle myosin heavy chain promoter directs gene expression into the vascular system of transgenic mice and rabbits.

Franz WM, Mueller OJ, Fleischmann M, Babij P, Frey N, Mueller M, Besenfelder U, Moorman AF, Brem G, Katus HA. Franz WM, et al. Among authors: frey n. Cardiovasc Res. 1999 Sep;43(4):1040-8. doi: 10.1016/s0008-6363(99)00173-x. Cardiovasc Res. 1999. PMID: 10615431

10

Risk stratification and therapeutic decision making in patients with acute coronary syndrome--the role of cardiac troponin T.

Hartmann F, Giannitsis E, Kurowski V, Frey N, Kampmann M, Katus HA. Hartmann F, et al. Among authors: frey n. Clin Chem Lab Med. 1999 Nov-Dec;37(11-12):1107-11. doi: 10.1515/CCLM.1999.161. Clin Chem Lab Med. 1999. PMID: 10726819 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

817 results

Search Page

Filters